ID   STK25_HUMAN             Reviewed;         426 AA.
AC   O00506; A8K6Z3; A8K7D2; B7Z9K1; Q15522; Q5BJF1;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   12-OCT-2022, entry version 212.
DE   RecName: Full=Serine/threonine-protein kinase 25;
DE            EC=2.7.11.1;
DE   AltName: Full=Ste20-like kinase;
DE   AltName: Full=Sterile 20/oxidant stress-response kinase 1;
DE            Short=SOK-1;
DE            Short=Ste20/oxidant stress response kinase 1;
GN   Name=STK25; Synonyms=SOK1, YSK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8887545; DOI=10.1002/j.1460-2075.1996.tb00831.x;
RA   Pombo C.M., Bonventre J.V., Molnar A., Kyriakis J., Force T.;
RT   "Activation of a human Ste20-like kinase by oxidant stress defines a novel
RT   stress response pathway.";
RL   EMBO J. 15:4537-4546(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9160885; DOI=10.1038/sj.onc.1201043;
RA   Osada S., Izawa M., Saito R., Mizuno K., Suzuki A., Hirai S., Ohno S.;
RT   "YSK1, a novel mammalian protein kinase structurally related to Ste20 and
RT   SPS1, but is not involved in the known MAPK pathways.";
RL   Oncogene 14:2047-2057(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, ACTIVITY REGULATION, PHOSPHORYLATION AT THR-174, SUBCELLULAR
RP   LOCATION, INTERACTION WITH GOLGA2, AND MUTAGENESIS OF LYS-49 AND ASP-158.
RX   PubMed=15037601; DOI=10.1083/jcb.200310061;
RA   Preisinger C., Short B., De Corte V., Bruyneel E., Haas A., Kopajtich R.,
RA   Gettemans J., Barr F.A.;
RT   "YSK1 is activated by the Golgi matrix protein GM130 and plays a role in
RT   cell migration through its substrate 14-3-3zeta.";
RL   J. Cell Biol. 164:1009-1020(2004).
RN   [10]
RP   INTERACTION WITH CTTNBP2NL.
RX   PubMed=18782753; DOI=10.1074/mcp.m800266-mcp200;
RA   Goudreault M., D'Ambrosio L.M., Kean M.J., Mullin M.J., Larsen B.G.,
RA   Sanchez A., Chaudhry S., Chen G.I., Sicheri F., Nesvizhskii A.I.,
RA   Aebersold R., Raught B., Gingras A.C.;
RT   "A PP2A phosphatase high density interaction network identifies a novel
RT   striatin-interacting phosphatase and kinase complex linked to the cerebral
RT   cavernous malformation 3 (CCM3) protein.";
RL   Mol. Cell. Proteomics 8:157-171(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Oxidant stress-activated serine/threonine kinase that may
CC       play a role in the response to environmental stress. Targets to the
CC       Golgi apparatus where it appears to regulate protein transport events,
CC       cell adhesion, and polarity complexes important for cell migration.
CC       {ECO:0000269|PubMed:15037601}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ACTIVITY REGULATION: Interaction with Golgi matrix protein GOLGA2 leads
CC       to autophosphorylation on Thr-174, possibly as a consequence of
CC       stabilization of dimer formation. The C-terminal non-catalytic region
CC       inhibits the kinase activity. {ECO:0000269|PubMed:15037601}.
CC   -!- SUBUNIT: Homodimer. Interacts with CTTNBP2NL.
CC       {ECO:0000269|PubMed:15037601, ECO:0000269|PubMed:18782753}.
CC   -!- INTERACTION:
CC       O00506; Q9Y376: CAB39; NbExp=4; IntAct=EBI-618295, EBI-306905;
CC       O00506; O95273: CCNDBP1; NbExp=3; IntAct=EBI-618295, EBI-748961;
CC       O00506; Q8NHQ1: CEP70; NbExp=3; IntAct=EBI-618295, EBI-739624;
CC       O00506; Q08379: GOLGA2; NbExp=16; IntAct=EBI-618295, EBI-618309;
CC       O00506; A6NEM1: GOLGA6L9; NbExp=3; IntAct=EBI-618295, EBI-5916454;
CC       O00506; Q8IYA8: IHO1; NbExp=3; IntAct=EBI-618295, EBI-8638439;
CC       O00506; Q9BUL8: PDCD10; NbExp=30; IntAct=EBI-618295, EBI-740195;
CC       O00506; O43815: STRN; NbExp=5; IntAct=EBI-618295, EBI-1046642;
CC       O00506; P14373: TRIM27; NbExp=6; IntAct=EBI-618295, EBI-719493;
CC       O00506; P63104: YWHAZ; NbExp=2; IntAct=EBI-618295, EBI-347088;
CC       O00506; Q62839: Golga2; Xeno; NbExp=2; IntAct=EBI-618295, EBI-618335;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15037601}. Golgi
CC       apparatus {ECO:0000269|PubMed:15037601}. Note=Localizes to the Golgi
CC       apparatus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O00506-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O00506-2; Sequence=VSP_054397;
CC       Name=3;
CC         IsoId=O00506-3; Sequence=VSP_054683;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Highest levels are found in
CC       testis, large intestine, brain and stomach followed by heart and lung.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/stk25/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X99325; CAA67700.1; -; mRNA.
DR   EMBL; D63780; BAA20420.1; -; mRNA.
DR   EMBL; AK291808; BAF84497.1; -; mRNA.
DR   EMBL; AK291947; BAF84636.1; -; mRNA.
DR   EMBL; AK315966; BAH14337.1; -; mRNA.
DR   EMBL; BT019961; AAV38764.1; -; mRNA.
DR   EMBL; AC110299; AAY14683.1; -; Genomic_DNA.
DR   EMBL; DQ093965; AAY88740.1; -; Genomic_DNA.
DR   EMBL; CH471063; EAW71265.1; -; Genomic_DNA.
DR   EMBL; BC007852; AAH07852.1; -; mRNA.
DR   EMBL; BC091505; AAH91505.1; -; mRNA.
DR   CCDS; CCDS2549.1; -. [O00506-1]
DR   CCDS; CCDS63199.1; -. [O00506-3]
DR   CCDS; CCDS63200.1; -. [O00506-2]
DR   PIR; S71886; S71886.
DR   RefSeq; NP_001258906.1; NM_001271977.1. [O00506-1]
DR   RefSeq; NP_001258907.1; NM_001271978.1. [O00506-1]
DR   RefSeq; NP_001258908.1; NM_001271979.1. [O00506-2]
DR   RefSeq; NP_001258909.1; NM_001271980.1. [O00506-2]
DR   RefSeq; NP_001269234.1; NM_001282305.1. [O00506-3]
DR   RefSeq; NP_001269236.1; NM_001282307.1. [O00506-3]
DR   RefSeq; NP_001269237.1; NM_001282308.1. [O00506-3]
DR   RefSeq; NP_006365.2; NM_006374.4. [O00506-1]
DR   PDB; 2XIK; X-ray; 1.97 A; A=1-293.
DR   PDB; 3W8H; X-ray; 2.43 A; B=355-426.
DR   PDB; 4NZW; X-ray; 3.58 A; B=1-293.
DR   PDB; 7Z4V; X-ray; 1.64 A; A=1-294.
DR   PDBsum; 2XIK; -.
DR   PDBsum; 3W8H; -.
DR   PDBsum; 4NZW; -.
DR   PDBsum; 7Z4V; -.
DR   AlphaFoldDB; O00506; -.
DR   SMR; O00506; -.
DR   BioGRID; 115757; 84.
DR   DIP; DIP-34269N; -.
DR   IntAct; O00506; 64.
DR   MINT; O00506; -.
DR   STRING; 9606.ENSP00000325748; -.
DR   BindingDB; O00506; -.
DR   ChEMBL; CHEMBL5552; -.
DR   DrugCentral; O00506; -.
DR   GlyGen; O00506; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O00506; -.
DR   PhosphoSitePlus; O00506; -.
DR   SwissPalm; O00506; -.
DR   BioMuta; STK25; -.
DR   EPD; O00506; -.
DR   jPOST; O00506; -.
DR   MassIVE; O00506; -.
DR   MaxQB; O00506; -.
DR   PaxDb; O00506; -.
DR   PeptideAtlas; O00506; -.
DR   PRIDE; O00506; -.
DR   ProteomicsDB; 1868; -.
DR   ProteomicsDB; 47947; -. [O00506-1]
DR   ProteomicsDB; 7036; -.
DR   Antibodypedia; 34565; 263 antibodies from 31 providers.
DR   DNASU; 10494; -.
DR   Ensembl; ENST00000316586.9; ENSP00000325748.4; ENSG00000115694.15. [O00506-1]
DR   Ensembl; ENST00000401869.5; ENSP00000385687.1; ENSG00000115694.15. [O00506-1]
DR   Ensembl; ENST00000403346.7; ENSP00000384162.3; ENSG00000115694.15. [O00506-1]
DR   Ensembl; ENST00000405585.5; ENSP00000385541.1; ENSG00000115694.15. [O00506-2]
DR   Ensembl; ENST00000405883.7; ENSP00000384444.3; ENSG00000115694.15. [O00506-2]
DR   Ensembl; ENST00000535007.5; ENSP00000446008.1; ENSG00000115694.15. [O00506-3]
DR   Ensembl; ENST00000543554.5; ENSP00000444886.1; ENSG00000115694.15. [O00506-3]
DR   GeneID; 10494; -.
DR   KEGG; hsa:10494; -.
DR   MANE-Select; ENST00000316586.9; ENSP00000325748.4; NM_001271977.2; NP_001258906.1.
DR   UCSC; uc002wbm.5; human. [O00506-1]
DR   CTD; 10494; -.
DR   DisGeNET; 10494; -.
DR   GeneCards; STK25; -.
DR   HGNC; HGNC:11404; STK25.
DR   HPA; ENSG00000115694; Group enriched (skeletal muscle, tongue).
DR   MIM; 602255; gene.
DR   neXtProt; NX_O00506; -.
DR   OpenTargets; ENSG00000115694; -.
DR   PharmGKB; PA36211; -.
DR   VEuPathDB; HostDB:ENSG00000115694; -.
DR   eggNOG; KOG0201; Eukaryota.
DR   GeneTree; ENSGT00940000153476; -.
DR   InParanoid; O00506; -.
DR   OMA; REFANQH; -.
DR   OrthoDB; 1115738at2759; -.
DR   PhylomeDB; O00506; -.
DR   TreeFam; TF354217; -.
DR   PathwayCommons; O00506; -.
DR   SignaLink; O00506; -.
DR   SIGNOR; O00506; -.
DR   BioGRID-ORCS; 10494; 11 hits in 1114 CRISPR screens.
DR   ChiTaRS; STK25; human.
DR   GeneWiki; STK25; -.
DR   GenomeRNAi; 10494; -.
DR   Pharos; O00506; Tchem.
DR   PRO; PR:O00506; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; O00506; protein.
DR   Bgee; ENSG00000115694; Expressed in hindlimb stylopod muscle and 181 other tissues.
DR   ExpressionAtlas; O00506; baseline and differential.
DR   Genevisible; O00506; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0007409; P:axonogenesis; IEA:Ensembl.
DR   GO; GO:0051683; P:establishment of Golgi localization; IMP:UniProtKB.
DR   GO; GO:0007163; P:establishment or maintenance of cell polarity; IEA:Ensembl.
DR   GO; GO:0051645; P:Golgi localization; IDA:UniProtKB.
DR   GO; GO:0090168; P:Golgi reassembly; IMP:UniProtKB.
DR   GO; GO:0036481; P:intrinsic apoptotic signaling pathway in response to hydrogen peroxide; IGI:UniProtKB.
DR   GO; GO:0050772; P:positive regulation of axonogenesis; IEA:Ensembl.
DR   GO; GO:0032874; P:positive regulation of stress-activated MAPK cascade; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IDA:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   CDD; cd06642; STKc_STK25; 1.
DR   Gene3D; 1.10.12.70; -; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR046409; PDC10_dimerisation_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR035060; STK_STK25.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cytoplasm;
KW   Golgi apparatus; Kinase; Magnesium; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN           1..426
FT                   /note="Serine/threonine-protein kinase 25"
FT                   /id="PRO_0000086713"
FT   DOMAIN          20..270
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          291..355
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        140
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         26..34
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         49
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         174
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:15037601"
FT   MOD_RES         278
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z2W1"
FT   VAR_SEQ         1..94
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054683"
FT   VAR_SEQ         11..87
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054397"
FT   VARIANT         64
FT                   /note="Q -> H (in dbSNP:rs34341643)"
FT                   /id="VAR_051674"
FT   MUTAGEN         49
FT                   /note="K->R: Loss of kinase activity and
FT                   autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15037601"
FT   MUTAGEN         158
FT                   /note="D->A: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:15037601"
FT   CONFLICT        347..348
FT                   /note="EP -> DA (in Ref. 1; CAA67700)"
FT                   /evidence="ECO:0000305"
FT   TURN            5..7
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           8..10
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           16..18
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   STRAND          20..27
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   STRAND          32..39
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   TURN            40..42
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   STRAND          45..52
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   TURN            53..56
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           57..59
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           60..71
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   STRAND          81..87
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   STRAND          90..96
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           103..106
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   TURN            107..109
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           114..133
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           143..145
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   STRAND          146..148
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   STRAND          154..156
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   STRAND          170..172
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           179..181
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           184..187
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           195..210
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   TURN            214..217
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           220..226
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   TURN            227..229
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           241..250
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           255..257
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           261..264
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           268..273
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           277..280
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           281..292
FT                   /evidence="ECO:0007829|PDB:7Z4V"
FT   HELIX           357..360
FT                   /evidence="ECO:0007829|PDB:3W8H"
FT   HELIX           362..374
FT                   /evidence="ECO:0007829|PDB:3W8H"
FT   TURN            375..377
FT                   /evidence="ECO:0007829|PDB:3W8H"
FT   HELIX           381..396
FT                   /evidence="ECO:0007829|PDB:3W8H"
FT   HELIX           400..414
FT                   /evidence="ECO:0007829|PDB:3W8H"
SQ   SEQUENCE   426 AA;  48112 MW;  183CE5700FCEA716 CRC64;
     MAHLRGFANQ HSRVDPEELF TKLDRIGKGS FGEVYKGIDN HTKEVVAIKI IDLEEAEDEI
     EDIQQEITVL SQCDSPYITR YFGSYLKSTK LWIIMEYLGG GSALDLLKPG PLEETYIATI
     LREILKGLDY LHSERKIHRD IKAANVLLSE QGDVKLADFG VAGQLTDTQI KRNTFVGTPF
     WMAPEVIKQS AYDFKADIWS LGITAIELAK GEPPNSDLHP MRVLFLIPKN SPPTLEGQHS
     KPFKEFVEAC LNKDPRFRPT AKELLKHKFI TRYTKKTSFL TELIDRYKRW KSEGHGEESS
     SEDSDIDGEA EDGEQGPIWT FPPTIRPSPH SKLHKGTALH SSQKPAEPVK RQPRSQCLST
     LVRPVFGELK EKHKQSGGSV GALEELENAF SLAEESCPGI SDKLMVHLVE RVQRFSHNRN
     HLTSTR
//
